WS #15455
The healthcare and tech-health sectors are seeing positive analyst sentiment, with Barclays raising price targets for Agilent Technologies and 10x Genomics, and maintaining an Overweight on both. Stifel also upgraded Zscaler, citing strong guidance. This cluster of upgrades suggests that despite the broader market weakness, certain high-quality growth names in healthcare IT and life sciences are attracting institutional interest. The positive sentiment is isolated to these specific names and does not yet reflect a broader sector rotation into healthcare.
Healthcare & Biotech Analyst Activity
The healthcare and tech-health sectors are seeing positive analyst sentiment, with Barclays raising price targets for Agilent Technologies and 10x Genomics, and maintaining an Overweight on both. Stifel also upgraded Zscaler, citing strong guidance. This cluster of upgrades suggests that despite the broader market weakness, certain high-quality growth names in healthcare IT and life sciences are attracting institutional interest. The positive sentiment is isolated to these specific names and does not yet reflect a broader sector rotation into healthcare.